ArticleAmerican journal of respiratory and critical care medicine2026
Inhaled anti-thymic stromal lymphopoietin antibody fragment, ecleralimab, in severe asthma: A placebo-controlled, multicenter, double-blind, randomized, phase 2b clinical trial.
Alexander J Mackay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.